⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
SUMO Pathway Modulators (TAK-981, SENP Modulators)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-21 — Orchestrating Stress Granule Dynamics by SUMOylation: A New Frontier in Treating Stress-Induced Age-Related Diseases.: Mechanistic review (Ageing Res Rev-style) reframes SUMOylation as a biophysical switch governing stress-granule nucleation and disassembly, and catalogs TAK-981, SENP modulators (e.g., Momordin Ic), and natural-product SUMO modulators as candidate correctors of SG dyshomeostasis in age-related disease — no human outcome data. [mechanism-plausible] (novelty: 3)
Open questions
Related
Contributing findings
Orchestrating Stress Granule Dynamics by SUMOylation: A New Frontier in Treating Stress-Induced Age-Related Diseases.
21-sep-2026
novelty 3
per-area 3
strengthens